Stock selection in the information technology and financials sectors contributed to the relative performance of the fund.

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) is among the best US stocks under $10 to invest in. Catherine Novack, an analyst at JonesTrading, has raised the price target on Aldeyra Therapeutics, Inc.

Three Motley Fool contributors think they've found unstoppable dividend stocks to buy right now. Here's why they picked ...

AbbVie has delivered strong returns and dividend growth, with solid prospects but notable risks creating near-term ...

In a report released today, Gary Nachman from Raymond James reiterated a Buy rating on AbbVie, with a price target of $236.00. The company’s shares closed yesterday at $209.50. Take advantage of ...